Results 111 to 120 of about 239,516 (296)
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
Background The aims of this study were to establish national disability weights based on the health state preferences of a Dutch general population sample, examine the relation between results and respondent’s characteristics, and compare disability ...
Juanita A. Haagsma +1 more
doaj +1 more source
Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL
ABSTRACT Objective Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact ...
Léa Aguilhon +5 more
wiley +1 more source
Background: This study aimed at estimating the incidence, mortality, burden, and geographical distribution of malaria between 2002 and 2015 in Iran. Methods: DALYs index was used to estimate the burden of malaria.
Bakhtiar PIROOZI +6 more
doaj
: The first objective of this study was to quantify the impact and disability weight (DW) of frequent diseases or syndromes of preweaning dairy calves using the perceptions of producers and veterinarians.
Jean Silva Ramos +6 more
doaj +1 more source
Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree +9 more
wiley +1 more source
Disability Adjusted Life Years (DALYs) for Decision-Making?
Disability-adjusted life years (DALYs) were introduced in 1993 amid the pages and policy directives of the World Development Report ‘Investing in Health’ (World Bank, 1993).
Fox-Rushby, J.; id_orcid
core +1 more source
Age-standardized rates of incidence and mortality for leishmaniasis per 100,000 inhabitants and relative change regarding years of life lost (YLL), years lived with disability (YLD), and disability-adjusted life years (DALY), Brazil,1990–2016, GBD Study ...
Valdelaine Etelvina Miranda de Araújo (184729) +5 more
core +1 more source
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe +7 more
wiley +1 more source
Estimated disability-adjusted life years (DALY) of indicators of maternal and child health.
Estimated disability-adjusted life years (DALY) of indicators of maternal and child health.
Lara Marina Cruz Lino (18271565) +3 more
core +1 more source

